Australia markets open in 9 hours 49 minutes

Processa Pharmaceuticals, Inc. (PCSA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2496+0.6296 (+38.86%)
As of 10:11AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
10,391
5,800
11,494
6,878
3,172
Selling general and administrative
7,436
5,658
8,763
4,689
3,264
Total operating expenses
17,827
11,457
20,257
11,567
6,437
Operating income or loss
-17,827
-11,457
-20,257
-11,567
-6,437
Interest expense
-
-
-
0.362
281.122
Total other income/expenses net
-
-
-7,268
-402.812
-8,700
Income before tax
-17,777
-11,122
-27,424
-11,958
-15,415
Income tax expense
-181.752
0
0
-530.611
-1,001
Income from continuing operations
-17,596
-11,122
-27,424
-11,428
-14,414
Net income
-17,596
-11,122
-27,424
-11,428
-14,414
Net income available to common shareholders
-17,596
-11,122
-27,424
-11,428
-19,040
Basic EPS
-22.80
-
-34.05
-15.00
-50.80
Diluted EPS
-22.80
-
-34.05
-15.00
-50.80
Basic average shares
1,165
-
805.477
765.973
374.983
Diluted average shares
1,165
-
805.477
765.973
374.983